A Comprehensive Report for decision making
Drug Developer's Intelligence Report
Oncology Intelligence
2017
Latest Updated Report available for Purchase
RELEASED - JANUARY 2017
It is an excellent report that has a wide variety of oncology information all in one place.
- Dr. Oleh Denysyk
OI 2017 Vs OI 2014
(in terms of Oncology Drug Developers Number)
UPDATED DATA for
ACCURATE DECISIONS
Â
OI 2017 is a key update over previous report OI 2014, as it may covers 220 more oncology drug developers than the previous report. It also abandoned 103 companies, which were earlier covered in OI 2014, which were either acquired/merged or closed during the period.
largest coverage
providing intelligence at fingertips
1
Countries
Largest Coverage with 32 Countries covered Globally
1
Drug developers
523 Clinical, 360 Preclinical Companies Profiles
1
+
Molecules
Individual Drug Mechanism of Action & Drug Target
1
+
Cancer Targets
Emerging Cancer Drug Targets Details
intelligence supercharged
1055 pages full of insights
Other Reports in this series
Oncology Intelligence 2013
Comprehensive Decision Making Intelligence derived from Active 624 Oncology Drug Developers.
Oncology Intelligence 2014
Comprehensive Decision Making Intelligence derived from Active 931 Oncology Drug Developers.
Oncology Intelligence 2017
Comprehensive Decision Making Intelligence derived from Active 1047 Oncology Drug Developers.
Oncology Intelligence 2020
Upcoming Comprehensive Decision Making Report derived from Active 1250+ Oncology Drug Developers.